InvestorsHub Logo
Followers 30
Posts 2559
Boards Moderated 0
Alias Born 04/01/2009

Re: MinnieM post# 157631

Sunday, 08/28/2016 5:30:01 PM

Sunday, August 28, 2016 5:30:01 PM

Post# of 403047
Karin,

In the case of Cellceutix's drugs, I believe we should have a better than average chance of advancing to the next Phase in each compound because of how sharp Menon is in interpreting the data and deciding what compounds should advance at what dosages. All IMHO, of course.

All I say is IMHO and not to be construed as investment advice. I know nothing, as informed frequently by my wife.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News